Future Therapies in cGvHD

Opinion
Video

Dr. Zeiser and Dr. Chao review ongoing clinical trials in the management of cGvHD – specifically the use of axatilimab and abatacept in SR/D cGvHD.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Newsletter

      Stay up to date on practice-changing data in community practice.

      Subscribe Now!
      Recent Videos
      2 experts in this video
      The Evolving Role of Lenvatinib in the HCC Therapeutic Landscape
      2 experts in this video
      Second-Line Therapy in Advanced HCC: Treatment Considerations and Evolving Options
      2 experts in this video
      Lenvatinib in Advanced HCC: Considerations for Monotherapy and Combination Regimens
      2 experts in this video
      First-Line Therapy for Advanced HCC: The Role of TKIs and ICIs
      2 experts in this video
      Considerations for Treatment Approaches in Intermediate-Stage HCC
      2 experts in this video
      Navigating the Evolving First-Line Treatment Regimens in Intermediate-Stage HCC
      2 experts in this video
      When to Move Beyond TACE: The Expanding Role of Systemic Therapy in Intermediate-Stage HCC
      2 experts in this video
      Current Treatment Practices in Embolization-Eligible HCC
      Academic Perspectives for LR-MDS Treatment in the Community
      Academic Perspectives for LR-MDS Treatment in the Community
      Sequencing Therapies in LR-MDS
      Sequencing Therapies in LR-MDS
      Related Content
      Precision Medicine Implemented in the Community Oncology Setting

      Precision Medicine Implemented in the Community Oncology Setting

      Marcus Neubauer, MD;Sagran Moodley
      March 15th 2024
      Article

      Technology plays a pivotal role in enhancing precision medicine within cancer care.

      Read More

      Yazan Madanat, MD, an expert on MDS

      Key Updates in Lower-Risk MDS

      Yazan Madanat, MD
      February 5th 2024
      Article

      In the fifth article of this series, Yazan Madanat, MD, reviews recent updates presented at the 2023 ASH Annual Meeting and discusses the evolving treatment landscape.

      Read More

      Evolving Treatments in Newly Diagnosed Multiple Myeloma (NDMM)

      Evolving Treatments in Newly Diagnosed Multiple Myeloma (NDMM)

      Peter Voorhees, MD
      January 25th 2024
      Article

      In this companion article, Dr Peter Voorhees provides insights into effective management of patients with newly diagnosed multiple myeloma (NDMM).

      Read More

      Translating Outcomes in Metastatic Colorectal Cancer (mCRC)

      Translating Outcomes in Metastatic Colorectal Cancer (mCRC)

      Tanios Bekaii -Saab, MD
      December 20th 2023
      Article

      In this companion article, Dr Tanios Bekaii-Saab provides insights into effective management of patients with metastatic colorectal cancer.

      Read More

      Breast cancer diagram

      Managing HER2+ Early Breast Cancer: A Focus on Target Therapy

      December 19th 2023
      Article

      Read More

      Sandra M. Swain, MD, FACP, FASCO, an expert on breast cancer

      Managing HER2+ Early Breast Cancer: Insights and Future Horizons

      Sandra M. Swain, MD, FACP, FASCO
      November 28th 2023
      Article

      Sandra M. Swain, MD, FACP, FASCO, discusses the potential role for HER2-directed TKIs for the treatment of patients with early-stage HER2+ breast cancer and shares insights about emerging data that could impact the future treatment landscape.

      Read More